Corcept Therapeutics Incorporated · NASDAQ:CORT

Robb Gary Charles exercised options for 17,493 Corcept Therapeutics Incorporated shares (Form 4)

Traded Sep 17, 2026 · Filed Sep 18, 2026

On Sep 17, 2026, Robb Gary Charles (Chief Business Officer) exercised options for 17,493 Corcept Therapeutics Incorporated shares at US$8.27 for US$145K, leaving 31,156 shares. Filed Sep 18, 2026 (Form 4).

Options exercised
17,493 shares
Price
US$8.27
Value
US$145K
Holding after
31,156 shares
Trading plan
No
Role
Chief Business Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 17, 2026Common StockOption exercise17,493US$8.2731,156Direct

Source

View original at SEC

Related